Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis

References

• Spruit MA, Janssen DJ, Franssen FM, Wouters EF. Rehabilitation and palliative care in lung fibrosis. Respirology 2009;14:781–787
   PubMed Web of Science ®Google Scholar
• Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 2011;6:e28486
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer: a survey. Biochim Biophys Acta 2007;1775:181–232
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513–10518
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843–854
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672–675
   PubMed Web of Science ®Google Scholar
• Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol 2012;41:1897–1912
   PubMed Web of Science ®Google Scholar
• Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabrò E, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011;108:3713–3718
   PubMed Web of Science ®Google Scholar
• Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. MiR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011;6:482–488
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H, Kosuga T, et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br J Cancer 2011;105:104–111
   PubMed Web of Science ®Google Scholar
• Munding JB, Adai AT, Maghnouj A, Urbanik A, Zöllner H, Liffers ST, Chromik AM, et al. Global microRNA expression profiling of micro dissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 2012;131:E86–E95
   PubMed Web of Science ®Google Scholar
• Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazović E, Radojević Z, Košnik M. Let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer. PLoS One 2012;7:e45577
   PubMed Web of Science ®Google Scholar
• Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009;284:23094–23106
   PubMed Web of Science ®Google Scholar
• Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, et al. MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 2011;6:e16979
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010;207:1589–1597
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 2008;3:1101–1108
   PubMed Web of Science ®Google Scholar
• Ge TT, Liang Y, Fu R, Wang GJ, Ruan EB, Qu W, Wang XM, et al. Expressions of miR-21, miR-155 and miR-210 in plasma of patients with lymphoma and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2012;20:305–309
   PubMedGoogle Scholar
• Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, Hu Z, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012;58:610–618
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang M, Lin G, Sun S, Li X, Qi J, Li J. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One 2012;7:e47003
   PubMed Web of Science ®Google Scholar
• Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, et al. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012;29:618–626
   PubMed Web of Science ®Google Scholar
• Cai EH, Gao YX, Wei ZZ, Chen WY, Yu P, Li K. Serum miR-21 expression in human esophageal squamous cell carcinomas. Asian Pac J Cancer Prev 2012;13:1563–1567
   PubMed Web of Science ®Google Scholar
• Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011;50:136–142
   PubMed Web of Science ®Google Scholar
• Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW, Lee CW, Wong YN, et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012;61:739–745
   PubMed Web of Science ®Google Scholar
• Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Hua M, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol 2011;12:861–869
   PubMed Web of Science ®Google Scholar
• Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 2009;200:916–925
   PubMed Web of Science ®Google Scholar
• Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 2011;104:847–851
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009;55:1944–1949
   PubMed Web of Science ®Google Scholar
• Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012;8:811–818
   PubMed Web of Science ®Google Scholar
• Pottier N, Maurin T, Chevalier B, Puisségur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009;4:e6718
   PubMed Web of Science ®Google Scholar
• Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009;1792:497–505
   PubMed Web of Science ®Google Scholar
• Behr J. Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment. Dtsch Med Wochenschr 2012;137:601–604
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, King TE Jr, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124:1215–1223
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Eqan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824
   PubMed Web of Science ®Google Scholar